Tranexamic acid ready to use - Hyloris Pharmaceuticals
Latest Information Update: 14 Oct 2021
Price :
$50 *
At a glance
- Originator Hyloris Pharmaceuticals
- Class Amines; Anti-infectives; Anti-inflammatories; Antifibrinolytics; Antihaemorrhagics; Cardiovascular therapies; Cyclohexanecarboxylic acids; Skin disorder therapies; Small molecules
- Mechanism of Action Antifibrinolytic agents; Plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Haemophilia; Haemorrhage